Nigel Beaton News Today

Investegate announcements from Biognosys AG, Biognosys Presenting Novel Cancer Research on its Proteomics Platforms and Advancing Data Analysis with the Launch of Proteoverse™ at the AACR Annual Meeting 2023

In collaboration with prominent biopharma companies and academic institutions, Biognosys will demonstrate the technological advances and versatility of the TrueDiscovery, TrueTarget, and TrueSignature

The expansion is part of the company’s growth strategy for North America and will foster collaboration with life science companies and academiaAn inauguration event will take place on October 12, featuring presentations from collaborators at NeoGenomics, Takeda and KymeraZURICH, Switzerland and CAMBRIDGE, Mass...

Investegate announcements from Biognosys AG, Biognosys Expands Its Global Presence with a US Office in Biopharma Hub Cambridge, Massachusetts

Data from Biognosys and its collaborators demonstrate the technological advances and utility of their proteomics platforms in oncology R&D and clinical settings Biognosys, a leader in next-generation